Pacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan

MT Newswires Live

2025/06/03

Pacific Edge (NZE:PEB) raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan (SPP) for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.

The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.

The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2540674198"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540674198\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2540674198?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-03 13:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540674198","market":"sg","top_or_hot":-1,"title":"Pacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan","media":"MT Newswires Live","content":"<html><body><p> Pacific Edge (NZE:PEB) raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan (SPP) for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.</p><p>The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.</p><p>The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-06-03 13:19</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Pacific Edge (NZE:PEB) raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan (SPP) for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.</p><p>The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.</p><p>The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2540674198","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540674198","pubTimestamp":1748927968,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan  for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7067":"生物科技","PEB.NZ":"Pacific Edge Limited Ordinary Shares","BK4215":"住宅房地产投资信托","BK8033":"生物科技","BK4588":"碎股","BK4585":"ETF&股票定投概念","PEB.AU":"PACIFIC EDGE LTD","EQR":"资产住宅公司"},"translate_title":"Pacific Edge完成1600万新西兰元股权融资，超额完成目标；拟启动500万新西兰元股票购买计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.NZ":1,"PEB.AU":0.9,"EQR":1},"content_text":"Pacific Edge (NZE:PEB) raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan (SPP) for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}